Reading time is 4 mins
.
.
DOES THE IMPLANT CAUSE CANCER?
It is being investigated whether there is a relationship between intra oral cancer cell development and the implant. But both there are not enough studies, and it has not yet been proven that the implant directly causes cancer
Of 4 – 6 Percent of all malignant tumors are located in the head and neck area. About half of them are located in the oral cavity, and intraoral cancer cells make up about 90 percent of the total. Tumors that are usually found in men over the age of 65 who have a habit of using tobacco and alcohol are defined as bad tumors. However, this trend has begun to change, and more and more bad tumors are observed in patients under the age of 45, women without any risk factors, adolescents, even children. At the same time, these have also been associated with other less typical risk factors: nutritional deficiencies, too high radiation exposure, irritating factors of dental or implant origin.
.
THERE ARE VERY FEW PUBLICATIONS
Dental implants have become one of the best options for treating patients without teeth in terms of oral rehabilitation and are considered the only form of treatment for some patients. Due to the universal use of dental implants, an increase in the number of confusion about their use is reported in the literature. The most common among such tangles are inflammatory processes affecting bone and soft tissues, known as periimplant. These conditions are often clinically edema, redness, increase the volume of tissue cells, and even that occurs with soft tissue injuries, which can sometimes be malignant changes, differential diagnosis that requires views.
To date, very few cases have been published on intraoral cancer cells with dental implants. There are even fewer publications on the primary malignant cancer cell in patients with a history of malignant disease at the local or regional level. But with the increase in the number of implants made, it is expected that we will see an increase in cases of intraoral cancer cells.
An assessment of cases published in the literature on implant associated oral cancers follows, said Turkey Medicals, “we can examine whether there is a direct relationship between implant and intraoral cancer cell development and evaluate which mechanism implants can be considered a risk.”
.
LOSS OF GUM CONNECTION CAN BE CAUSED BY
The mechanism by which dental implants can contribute to the development of intraoral cancer cells is very controversial. It is argued that implant placement can contribute to the development of intraoral cancer cells from the epithelium to the spongy bone due to the loss of gum tissue. The gum connection in the implant is constantly experiencing inflammation, which can affect tissue balance and, accordingly, play an important role in the development of cancer: simple proteins, the factor that ensures the destruction of cancerous cells. Additional risk factors may also be between, such as uncomfortable factors such as improperly installed dentures or poor oral hygiene, alcohol and tobacco consumption. In the literature studied, the vast majority of the cases mentioned consist of patients with a history of cancer in other parts of the body prior to intraoral cancer cell or implant placement.
.
PAY ATTENTION TO WHAT VITAMIN DEFICIENCIES ARE
Nutritional deficiencies can explain the rapid evolution of tissue disorder, given that gastric plastic reduces the area of absorption of certain nutrients and vitamins at the gastric level, increases the rate of gastric and intestinal transit, and also reduces the absorption of certain essential elements. Each of them is associated with the factor of local irritation of the implants and can explain the process in a patient who does not have any toxic habits.
Among the 18 patients in the study, only 9 of the patients showed no history of malignant cancer or cancer. in 2006, two cases of intraoral cancer cells were presented in a 66 year old female patient and a 69 year old male patient with no history of malignant tissue disorders or risk factors. In both cases, it turned out that the apparent tissue disorder was compatible with those associated with inflammatory processes affecting bone and soft tissues.
.
THERE WAS NO TISSUE INFLAMMATION
In 2009, they reported a 71-year-old male patient with a tissue disorder in his lower left region, associated with implants supporting a fixed prosthesis placed five years earlier. The patient had no history of cancer, inflammatory conditions affecting bone and soft tissues, or inflammation of the tissue, or any known risk factors. in 2008, a 62-year-old female patient with no history of cancer, whose risk factors were moderate alcohol consumption and formerly smoked, was presented with an inflammation around implants placed in the lower incisor region. Examination of tissues under a light microscope revealed moderately differentiated cancer cells that require surgical intervention, removing the lymph node by surgery on the same side of the body, as well as safety limits.
A 80-year-old male patient with a history of high blood pressure and high uric acid levels in his blood who had two implants in the lower right jaw about five years ago, then developed an outward-growing tissue disorder, was presented in 2010. The patient did not present risk factors and was regularly seen for check-ups. As an initial treatment, the inflammations affecting the bone and soft tissues were cleared and a biopsy was performed 10 days later. An examination with a light microscope revealed a well-differentiated cancer cell. Then the cancer cell was cut out and removed.
.
RISK FACTORS SHOULD BE DETERMINED
Before an implant treatment, the patient’s risk factors must be structured, and an appropriate cost benefit assessment must be performed for each patient. In patients with risk factors, regular check-ups in Turkey and oral cavity should be carried out a full examination, a lesion a biopsy to diagnose any problem as soon as possible and then in the probability of correct diagnosis of the disease for the purpose of examination under light microscopy of tissues should be performed.
The most common cancer cell associated with dental implants is peri implantitis (inflammation that affects bone and soft tissues); this is why it is necessary to monitor any of these symptoms thoroughly in order to perform the final cancer cell screening. Therefore, I believe that from a medical point of view, it should be possible to remove any implant installed on a prosthesis relatively conveniently for purpose of examining the gum-implant tissues and monitoring possible changes in this area.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.